Penbrook Management’s Aehr Test Systems AEHR Stock Holding History

Penbrook Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$518K	Hold	5,200	–	–	0.31%	65
2026 Q2	$500K	Sell	5,200 -74,315	-93%	-$6.79M	0.32%	64
2026 Q1	$2.95M	Sell	79,515 -35,385	-31%	-$1.13M	2.23%	9
2025 Q4	$2.32M	Sell	114,900 -1,350	-1%	-$32.7K	1.6%	13
2025 Q3	$3.5M	Sell	116,250 -10,000	-8%	-$217K	2.44%	9
2025 Q2	$1.63M	Buy	126,250 +84,875	+205%	+$808K	1.23%	15
2025 Q1	$302K	Buy	41,375 +7,550	+22%	+$83.5K	0.23%	84
2024 Q4	$563K	Buy	33,825 +6,825	+25%	+$91K	0.38%	55
2024 Q3	$347K	Sell	27,000 -580	-2%	-$8.39K	0.23%	75
2024 Q2	$308K	Buy	+27,580	New	+$321K	0.19%	77
2024 Q1	–	Sell	-8,080	Closed	-$214K	–	103
2023 Q4	$214K	Buy	+8,080	New	+$236K	0.14%	90

Other funds holding AEHR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Penbrook Management's AEHR Position: Q3 2026 in Review

Penbrook Management held its Aehr Test Systems (AEHR) position steady in Q3 2026 at 5,200 shares worth $518K. The position accounts for 0.31% of the portfolio, ranked #65.

Penbrook Management first reported a position in AEHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.5M in Q3 2025. 145 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

Penbrook Management held 5,200 shares of Aehr Test Systems worth $518K as of Q3 2026.
Penbrook Management left its Aehr Test Systems share count unchanged in Q3 2026.
Aehr Test Systems made up 0.31% of Penbrook Management's portfolio in Q3 2026, its #65 holding.
Penbrook Management first reported a position in Aehr Test Systems in Q4 2023 and has held it in 11 quarters since.
Penbrook Management's Aehr Test Systems position peaked at $3.5M in Q3 2025.
145 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on Penbrook Management's 13F filing for Q3 2026, filed 16 Oct 2026.